Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxRevenueSelling, General & Administrative
Others
Ratios

Odyssey Health (ODYY) EBIT (2016 - 2021)

Odyssey Health (ODYY) has 8 years of EBIT data on record, last reported at -$2.6 million in Q3 2021.

  • For Q3 2021, EBIT fell 125.45% year-over-year to -$2.6 million; the TTM value through Jul 2021 reached -$15.9 million, down 312.32%, while the annual FY2025 figure was -$1.0 million, 52.29% up from the prior year.
  • EBIT reached -$2.6 million in Q3 2021 per ODYY's latest filing, up from -$12.1 million in the prior quarter.
  • Across five years, EBIT topped out at -$26029.0 in Q1 2017 and bottomed at -$23.4 million in Q3 2019.
  • Average EBIT over 5 years is -$2.3 million, with a median of -$231760.0 recorded in 2018.
  • Peak YoY movement for EBIT: tumbled 28500.69% in 2019, then surged 95.06% in 2020.
  • A 5-year view of EBIT shows it stood at -$49497.0 in 2017, then fell by 5.87% to -$52404.0 in 2018, then plummeted by 2424.08% to -$1.3 million in 2019, then soared by 60.29% to -$525269.0 in 2020, then plummeted by 396.38% to -$2.6 million in 2021.
  • Per Business Quant database, its latest 3 readings for EBIT were -$2.6 million in Q3 2021, -$12.1 million in Q2 2021, and -$633792.0 in Q1 2021.